首页|LncRNA SOX2OT靶向SIRT1/自噬通路增强胆管癌细胞5-FU耐药

LncRNA SOX2OT靶向SIRT1/自噬通路增强胆管癌细胞5-FU耐药

扫码查看
目的 探讨LncRNA SOX2OT靶向SIRT1/自噬通路调节胆管癌细胞5-FU耐药的机制。方法 将未用5-FU处理HCCC-9810细胞和不同浓度(50、100、150、200 μg/mL)5-FU处理的HCCC-9810细胞分为对照组和模型组,qRT-PCR检测LncRNA SOX2OT、SIRT1 mRNA表达水平,Western blot检测SIRT1、Beclin1、LC3和p62蛋白表达。pcDNA3。1-SOX2OT和pcDNA3。1-NC转染HCCC-9810/5-FU耐药细胞,CCK-8检测细胞耐药性,划痕实验检测细胞迁移能力,qRT-PCR检测LncRNA SOX2OT、SIRT1 mRNA表达水平,Western blot检测SIRT1、Beclin1、LC3和p62表达。在以上基础上做了Rescue实验,将OV-SOX2OT(2 μg/孔)和si-NC(75 pmol/孔)、OV-SOX2OT(2 μg/孔)和si-SIRT1(75 pmol/孔)分别共转染HCCC-9810/5-FU耐药细胞,分组为OV-SOX2OT+si-NC组和OV-SOX2OT+si-SIRT1组,以证明LncRNA SOX2OT通过SIRT1影响自噬,并由此影响胆管癌细胞对5-FU的耐药性。RNA Pulldown验证SOX2OT与SIRT1的靶向结合关系。结果 不同浓度的5-FU均能抑制HCCC-9810细胞增殖(P<0。05)。与对照组相比,模型组SIRT1、Beclin1(P<0。001)和p62(P<0。01)蛋白表达、LC3Ⅱ/LC3Ⅰ比值(P<0。001)、SIRT1和LncRNA SOX2OT mRNA水平(P<0。05)均明显增加。与OV-NC组相比,OV-SOX2OT组细胞迁移能力、SIRT1、Beclin1(P<0。001)和p62(P<0。05)蛋白表达、LC3Ⅱ/LC3Ⅰ比值(P<0。001)、SIRT1和LncRNA SOX2OT mRNA(P<0。05)水平均明显增加。沉默SIRT1表达导致LncRNA SOX2OT过表达的HCCC-9810细胞对5-FU的耐药性显著降低。与OV-SOX2OT+ si-NC组相比,OV-SOX2OT+si-SIRT1组SIRT1(P<0。001)、p62和Beclin1(P<0。01)蛋白表达、LC3Ⅱ/LC3Ⅰ比值(P<0。01)、SIRT1 mRNA(P<0。05)水平均明显降低。RNA Pulldown检测结果显示SOX2OT能够直接与SIRT1结合。结论 LncRNA SOX2OT通过上调SIRT1表达促进自噬来增强胆管癌HCCC-9810细胞5-FU耐药性。
LncRNA SOX2OT enhances 5-fluorouracil resistance of cholangiocarcinoma cells by promoting autophagy via up-regulating SIRT1 expression
Objective To investigate the role of SIRT1/autophagy pathway in mediating the regulatory effect of lncRNA SOX2OT on 5-fluorouracil(5-FU)resistance in cholangiocarcinoma cells.Methods HCCC-9810 cells were used to construct a 5-FU-resistant cell model(HCCC-9810/5-FU cells),and the expression levels of lncRNA SOX2OT and SIRT1 mRNA and the protein expressions of SIRT1,Beclin1,LC3 and P62 were detected with qRT-PCR and Western blotting.The effects of transfection with a SOX2OT mimic on drug resistance and cell migration of HCCC-9810/5-FU cells were detected using CCK-8 assay and wound healing assay,and the changes in expressions of SOX2OT,SIRT1,Beclin1,LC3 and P62 were detected.Rescue experiment was performed by co-transfection of HCCC-9810/5-FU cells with both a SOX2OT-overexpressing plasmid and si-SIRT1 to confirm the role of SIRT1 in SOX2OT-mediated regulation of 5-FU resistance.A RNA pulldown assay was used to verify the targeted binding between SOX2OT and SIRT1.Results The proliferation of HCCC-9810 cells was significantly inhibited after treatment with different concentrations of 5-FU(P<0.05).The 5-FU-resistant cells showed significantly increased protein expressions of SIRT1,Beclin1 and p62,an increased LC3Ⅱ/LC3Ⅰ ratio,and enhanced expressions of SIRT1 mRNA and SOX2OT(P<0.05).Transfection of the resistant cells with SOX2OT mimic significantly enhanced cell migration and increased the protein expressions of SIRT1,Beclin1 and p62,the LC3Ⅱ/LC3Ⅰratio,and expression levels of SIRT1 mRNA and SOX2OT(P<0.05),and these changes were obviously attenuated by SIRT1 knockdown,which also resulted in lowered 5-FU resistance of the cells without significantly affecting the expression level of SOX2OT(P>0.05).RNA pulldown assay suggested that SOX2OT could directly bind to SIRT1.Conclusion LncRNA SOX2OT enhances 5-FU resistance in HCCC-9810 cells by promoting autophagy through up-regulating SIRT1 expression.

LncRNA SOX2OTSIRT1autophagycholangiocarcinoma cells5-FU resistant

辛辰、王笑影、李响、陈宇、王雪、宁佳曦、杨适、王忠琼

展开 >

西南医科大学附属医院消化内科,四川 泸州 646000

西南医科大学附属医院麻醉科,四川 泸州 646000

LncRNA SOX2OT SIRT1 自噬 胆管癌细胞 5-FU耐药

西南医科大学校级项目

2020ZRQNB054

2024

南方医科大学学报
南方医科大学

南方医科大学学报

CSTPCD北大核心
影响因子:1.654
ISSN:1673-4254
年,卷(期):2024.44(1)
  • 9